Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip

Capricor Therapeutics Inc. (NASDAQ: CAPR) Listen to this Section


$3.96
+0.0600 ( +1.54% ) 302.0K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Market Data


Open


$3.96

Previous close


$3.90

Volume


302.0K

Market cap


$128.85M

Day range


$3.85 - $4.08

52 week range


$2.68 - $8.22

Insider Ownership Transactions

Total Amount Purchased: -562,156.00 | $ -2,226,137.76

Date Type Amount Purchased Purchaser
2024-08-09 Sale -34000.00 Musket David B
2024-04-25 Sale -30000.00 COLLIER EARL M JR
2024-04-24 Sale -16156.00 Musket David B
2024-01-04 Sale -200000.00 Litvack Frank
2024-01-04 Sale -80000.00 Krasney Karen
2024-01-04 Sale -85000.00 Bergmann Anthony
2024-01-04 Sale -29250.00 Auwaerter Paul Gisbert
2024-01-04 Sale -29250.00 Sabar Karimah Es
2024-01-04 Sale -29250.00 DUNBAR GEORGE W JR
2024-01-04 Sale -29250.00 COLLIER EARL M JR

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 09, 2024
10-q Quarterly Reports 58 Aug 08, 2024
8-k 8K-related 15 Aug 07, 2024
8-k 8K-related 14 May 15, 2024
8-k 8K-related 13 May 15, 2024
10-q Quarterly Reports 57 May 14, 2024
8-k 8K-related 15 May 13, 2024
8-k 8K-related 42 Apr 29, 2024
4 Insider transactions 1 Apr 25, 2024
4 Insider transactions 1 Apr 24, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.